Javier Pinilla-Ibarz, MD, PhD

Associate Professor
Department of Oncologic Sciences
College of Medicine
University of South Florida
Tampa, Florida

Dr. Javier Pinilla-Ibarz received both his medical degree and PhD from the University of Zaragoza, School of Medicine, Spain. He completed a residency in medicine and a fellowship in hematology at La Paz University Hospital in Madrid, Spain, and also completed a residency in internal medicine at Cornell Medical Center, as well as a fellowship in hematology/oncology at the Memorial Sloan-Kettering Cancer Center. Dr. Pinilla-Ibarz is an associate professor in the Department of Oncologic Sciences, College of Medicine, University of South Florida.

Dr. Pinilla-Ibarz is an associate member of the Malignant Hematology and Immunology Program at the H. Lee Moffitt Cancer Center in Tampa, and is leading the chronic leukemia program whose principal interest is patients with myeloid and lymphoid chronic leukemia. He has participated in multiple clinical trials involving tyrosine kinase inhibitors, some of them now approved. Dr. Pinilla-Ibarz is also the director of immunotherapy for malignant hematology and has been involved in developing new immunotherapeutic approaches in chronic myelogenous leukemia (CML.) He is currently leading several clinical trials of peptide and cellular vaccines in different hematological disorders. Other research focuses are on the role of the bone marrow microenvironment in mediating resistance to TKIs and the interaction of TKIs with the immune system.

Dr. Pinilla-Ibarz frequently presents his findings at annual meetings of the American Hematology Association, American Society of Clinical Oncology, and other national/international meetings. His work has been published in journals including Blood, Nature Immunology, Seminars of Hematology, and Leukemia. He has also authored multiple book chapters.

Last modified: December 9, 2018